Fenfluramine hydrochloride is a phenethylamine-derived pharmaceutical compound that functions as a serotonin-releasing agent and reuptake inhibitor. While historically indicated as an appetite suppressant… Read more
Fenfluramine hydrochloride is a phenethylamine-derived pharmaceutical compound that functions as a serotonin-releasing agent and reuptake inhibitor. While historically indicated as an appetite suppressant for obesity, it is currently approved for the management of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome. Analytical laboratories require precise reference standards of fenfluramine hydrochloride to support essential testing protocols and ensure the integrity of pharmaceutical formulations. This category provides access to critical materials, including the primary active metabolite norfenfluramine, various pharmacopeial and non-pharmacopeial impurities, and a range of stable isotope-labelled compounds. These high-purity standards are vital for accurate impurity profiling, method validation, and routine quality control procedures. By utilizing these specialized compounds, researchers can facilitate robust quantitative and qualitative analyses, maintaining regulatory compliance and ensuring consistency throughout the pharmaceutical development lifecycle.